English
Trade
Titan Biotech share price
High risk
You have to be logged in to add this to Watchlist.- ₹972.45(-2.00%)November 7, 2025 15:15:00 PM IST
- NSE
- BSE
- Vol : 6.25K (NSE + BSE)Last 20 day avg : 22.93 K
Titan Biotech is trading -2.00% lower at Rs 972.45 as compared to its last closing price. Titan Biotech has been trading in the price range of 972.45 & 972.45. Titan Biotech has given 35.41% in this year & -9.60% in the last 5 days. Titan Biotech has TTM P/E ratio 15.18 as compared to the sector P/E of 19.68.The company posted a net profit of 6.86 Crores in its last quarter.Listed peers of Titan Biotech include Zenotech Laboratories (1.57%), Fredun Pharmaceuticals (1.01%), Titan Biotech (-2.00%).The Mutual Fund holding in Titan Biotech was at -% in . The MF holding has - from the last quarter. The FII holding in Titan Biotech was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Key Metrics
Updated on Nov 08, 2025, 09:35 AM UTC
- BetaLow volatility-0.15Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.02The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.20Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation-158.51The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Titan Biotech News
Titan Biotech Financials
Financials
View allFinancials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
- Income
- Balance Sheet
- Cash Flow
Loading...
Units in the chart are in crores
Insights
- Financial
- Valuation
Company is profitable- The company's revenue grew in June quarter by 7.84% from Rs 46.50 crore to Rs 43.11 crore, year-on-year
- The company has grown its June quarter profit by 7.24% from Rs 6.40 crore to Rs 6.86 crore, year-on-year
- The debt to equity of the company is lower than the industry median
- Company can comfortably pay off its interest obligations with its earnings
Titan Biotech Technical Analysis
Pivot Level - classic
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
- R1
- 1,025.85
- R2
- 1,039.20
- R3
- 1,065.90
Pivot999.15
- S1
- 985.80
- S2
- 959.10
- S3
- 945.75
Short Term
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Considers price movement over the last 6 months
Not Available
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Trends unavailable at the moment.
Titan Biotech Peers
Return Comparison
Peers Comparison
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Zenotech Laboratories | Neutral | 51.12 | 1.57 | 311.99 | 83.91 | 4.02 | - | - |
| Fredun Pharmaceuticals | Bullish | 1,564.00 | 1.01 | 749.25 | 18.16 | 2.72 | 0.09 | 11.69 |
| Titan Biotech | Bearish | 972.45 | -2.00 | 803.61 | 16.66 | 2.34 | 0.46 | 0.27 |
| Sms Lifesciences India | Moderately Bullish | 1,179.85 | 1.71 | 356.70 | 17.67 | 1.81 | 0.13 | 10.18 |
| Medico Remedies | Moderately Bullish | 49.95 | -0.28 | 407.11 | 33.82 | 5.48 | - | 0.59 |
Titan Biotech Shareholding
View AllShareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
Shareholding pattern for Titan Biotech is currently unavailable
Please check back later.
Shareholding Insights
- Promoter(s) holds a high stake in the company at 55.78%
Promoter(s) have decreased the stake in the company in last 12 months- FIIs are not invested in this company
- Mutual Funds are not invested in this company.
Titan Biotech Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-11 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-30 | Audited Results & Final Dividend |
| 2025-02-12 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
About the company Titan Biotech
- IndustryBiotechnology & Drugs
- ISININE150C01011
- BSE Code524717
- NSE Code
Titan Biotech Limited is an India-based manufacturer and exporter of biological products. The Company is a manufacturer of clinically approved collagen (fish, bovine, and chicken), skin care ingredients, bone and joint care ingredients, proteins, animal nutrition ingredients and many more. It can provide any microbiology product that its customers need from powder culture media to prepared media. Its product categories include food ingredients, collagen and proteins, pharmaceuticals and nutraceuticals, animal nutrition, probiotics and fermentation ingredients, agriculture products, and culture media. The Company's food ingredients include flavoring and food preservative and improvers. Its collagen and proteins include wheat protein hydrolysate and collagen peptides. Its nutraceuticals include milk protein and bovine cartilage extract. Its animal nutrition includes binding agent, chelates minerals and yeast. Its agriculture products include bio fungicide, insecticides and acaricides.
Titan Biotech Share Price FAQs
Titan Biotech is trading at 972.45 as on Fri Nov 07 2025 09:45:00. This is -2.00% lower as compared to its previous closing price of 992.25.
The market capitalization of Titan Biotech is 803.61 Cr as on Fri Nov 07 2025 09:45:00.
The 52 wk high for Titan Biotech is 1419.00 whereas the 52 wk low is 373.65
Titan Biotech can be analyzed on the following key metrics -
- TTM P/E: 15.18
- Sector P/E: 19.68
- Dividend Yield: 0.20%
- D/E ratio: -
Titan Biotech reported a net profit of 21.53 Cr in 2025.
Quick Links